HIV/hepatitis C virus (HCV) coinfected patients who have a high HCV load at the start of treatment for hepatitis C are the group of patients most likely to experience a relapse of their HCV infection, say Spanish researchers writing in the August 1st edition of the Journal of Acquired Immune Deficiency Syndromes.
Response to anti-HCV treatment after a month is also a good predictor of relapse but longer than standard duration of hepatitis C therapy does not improve the chances of HIV/HCV-coinfected patients clearing the virus,
One surprising finding was that HCV/HIV coinfected patients taking potent antiretroviral therapt at the same time as their HCV treatment were more likely to relapse (p = 0.04). The authors say that finding could indirectly reflect patients with more advanced HIV disease who may have lost some of the immune function involved in therapy-induced HCV clearance.read more
Subscribe to:
Post Comments (Atom)
1 comment:
I was diagnosed as HEPATITIS B carrier in 2013 with fibrosis of the
liver already present. I started on antiviral medications which
reduced the viral load initially. After a couple of years the virus
became resistant. I started on HEPATITIS B Herbal treatment from
ULTIMATE LIFE CLINIC (www.ultimatelifeclinic.com) in March, 2020. Their
treatment totally reversed the virus. I did another blood test after
the 6 months long treatment and tested negative to the virus. Amazing
Post a Comment